Analysis reveals increasing prevalence and treatment burden of nAMD in older age groups, suggesting additional contributing factors.
Between 2014 and 2019, the prevalence and treatment burden of nAMD increased substantially in Japan, with a disproportionate rise among older age groups in a super-aged population. Comorbidities did not account for the temporal increase, suggesting that factors beyond aging and comorbidity are contributing to the growing burden.
No takes yet. Share an insight, caveat, or question.
Akada et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: